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Abstract
Bacterial meningitis is an acute disease with high mortality that is reduced by early treatment. Identification of the causative
microorganism by culture is sensitive but slow. Large volumes of cerebrospinal fluid (CSF) are required to maximise
sensitivity and establish a provisional diagnosis.
We have utilised nuclear magnetic resonance (NMR) spectroscopy to rapidly characterise the biochemical profile of CSF
from normal rats and animals with pneumococcal or cryptococcal meningitis. Use of a miniaturised capillary NMR system
overcame limitations caused by small CSF volumes and low metabolite concentrations. The analysis of the complex NMR
spectroscopic data by a supervised statistical classification strategy included major, minor and unidentified metabolites.
Reproducible spectral profiles were generated within less than three minutes, and revealed differences in the relative
amounts of glucose, lactate, citrate, amino acid residues, acetate and polyols in the three groups. Contributions from
microbial metabolism and inflammatory cells were evident. The computerised statistical classification strategy is based on
both major metabolites and minor, partially unidentified metabolites. This data analysis proved highly specific for diagnosis
(100% specificity in the final validation set), provided those with visible blood contamination were excluded from analysis;
6–8% of samples were classified as indeterminate.
This proof of principle study suggests that a rapid etiologic diagnosis of meningitis is possible without prior culture. The
method can be fully automated and avoids delays due to processing and selective identification of specific pathogens that
are inherent in DNA-based techniques.
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Introduction
Bacterial meningitis is an acute disease with a high mortality
[1,2]. Severe neurological sequelae have been reported in 25% of
cases [3,4]. Outcomes are directly related to the speed with which
the diagnosis is established and therapy initiated. Conventional
diagnosis relies on screening examination of cerebrospinal fluid
(CSF) for non-specific markers such as inflammatory cells, proteins
and glucose, and the more specific but insensitive Gram stain for
micro-organisms, to distinguish rapidly between bacterial and
non-bacterial (most commonly viral and fungal) infection.
Ultimate confirmation of the diagnosis and identification of the
specific microbial pathogen by culture is sensitive and specific, but
slow. This might delay the most appropriate treatment. Relatively
large volumes of CSF are recommended to maximise sensitivity
and provide sufficient material for completion of the various
diagnostic tests.
Alternative approaches based on chemicals in CSF due to
production by the infection causing microorganism or due to the
immune response of the host are potentially useful for the
diagnosis of a variety of neurological diseases, including meningitis
[5]. Metabolic changes that reflect infection such as low glucose or
disproportionately elevated lactate are characteristic of bacterial
meningitis but have been poor discriminators in some studies [6–
8]. A disadvantage of these biochemical methods is that only
particular compounds are targeted by individual tests. High-
throughput technologies such as Nuclear Magnetic Resonance
(NMR), Infrared (IR) and Raman spectroscopy, chromatographic
methods and mass spectrometry, generate complex data (‘‘finger-
prints’’) based on chemical composition and metabolite profiles of
micro-organisms (metabolome) [9–13]. Such metabolomic meth-
ods can detect genotypic and phenotypic differences even in
closely related microorganisms and also in genetically modified
strains [13–17], with greater discriminatory power than
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niques characterise rapidly and simultaneously multiple chemical
compounds in biological fluids [10,19–28]. In addition, NMR
spectroscopy detects low molecular weight metabolites, requires
no time-consuming sample preparation and is non-destructive.
The metabolite composition of normal CSF has been studied
intensively by NMR spectroscopy [22,29,30]. CSF contains a
relatively limited repertoire of metabolites, compared with serum
or urine, that are relatively stable with diet and medication, and on
storage at room temperature for a short time [22,29,31]. CSF is
therefore a potentially useful biofluid for identifying metabolic
profiles of pathogens and the host response.
Computerised methods utilize the whole NMR spectrum and
include unnoticed (or unknown) compounds. In a pilot study of
acute meningitis, CSF spectra from small numbers of controls,
patients with viral meningitis and bacterial/fungal meningitis were
distinguished using an unsupervised cluster analysis method [8],
suggesting that classification according to etiology is possible using
larger data sets. Since human cases of meningitis caused by
different bacterial or fungal species are relatively uncommon in
developed countries and acquisition of sufficient spectral data
would require several years, a proof of principle study was
performed using rat models of meningitis. Repeated sampling of
small volumes of CSF from individual animals was made possible
by the use of a miniaturised micro NMR system [32,33].
In clinical practice, rapid identification of a specific bacterial or
fungal pathogen is important as it enables immediate initiation of
appropriate antimicrobial therapy based on predictable patterns of
antibiotic susceptibility and hence improves clinical outcomes. We
have utilised a metabolomic approach based on NMR spectra
from CSF of animal models to evaluate if metabolites produced by
an infection-causing microorganism or a specific immune response
can be utilised for diagnosis. This could provide the basis for
further development of the method on human CSF specimens.
The two disease models used were meningitis caused by
Cryptococcus neoformans and Streptococcus pneumoniae.
Results
Meningitis models and metabolite profiles
Meningitis was induced in Fisher 344 rats by injection of
Cryptococcus neoformans (N=31) or Streptococcus pneumoniae (N=30)
into the cisterna magna. CSF samples were collected from these
animals after first signs of meningitis and at several time points
thereafter. Control CSF samples were repeatedly collected from
sham injected animals (phosphate buffered saline (PBS), N=5) or
prior infection.
Metabolite composition of the CSF samples was studied by
NMR spectroscopy using either an NMR system equipped with an
1 mm micro probe or a conventional 5 mm probe. Figure 1 shows
typical 1D NMR spectra of CSF samples from control animals
(injected with PBS) and collected from animals with histologically
confirmed meningitis, four days after injection of 10
4 cfu of C.
neoformans and S. pneumoniae, respectively. Resonances in the 1D
NMR spectra from each pathology were assigned to respective
metabolites using 2D NMR correlation spectra from at least five
independent samples per category (see supporting material, Figure
S1).
Although the major metabolites in CSF samples from all three
categories were qualitatively similar for control and post-infection
CSF samples from individual animals, quantitative differences
were noted (supporting material, Table S1). CSF from infected
animals contained increased amounts of lactate (5–90%, using the
resonance at 1.31 ppm), decreased glucose (5–30%, resonance at
3.25 ppm) and marginally increased citrate (0–15% resonance at
2.45–2.75 ppm) and amino acid residues (0–15% for alanine
(1.49 ppm) and glutamine/glutamate (2.2–2.4 ppm)). For most
samples, only glutamine but no glutamate was detected. Some
infected CSF samples showed increased acetate (for 55% of S.
pneumoniae infections and for 30% of C. neoformans infections) and
Figure 1.
1H NMR spectra acquired with a 400 MHz spectrom-
eter equipped with probe for 1 mm sample tubes. NMR spectra
were acquired from the following samples: (A) CSF from a control
animal (before initiation of the infection), (B) CSF from an animal five
days after injection of S. pneumoniae (animal showed symptoms of
meningitis; heavy growth of S. pneumoniae from CSF confirmed
streptococcal meningitis), (C) CSF from an animal four days after
injection of C. neoformans (animal showed symptoms of meningitis,
heavy growth of C. neoformans from CSF confirmed cryptococcal
meningitis), (D) CSF heavily contaminated with blood (same animal as C
but collected three days after initiation of the infection). Abbreviations
refer to
1H NMR signal of the following metabolites: Ac – acetate, Ala –
alanine, Cit – citrate, b-glc (H-2) – H-2 resonance of b-glucose, Glc –
glucose, Gln – glutamine, Ha AA – resonances of H-a from amino acid
residues, Lac – lactate.
doi:10.1371/journal.pone.0005328.g001
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for 20% of C. neoformans infections).
Integral ratios of the most abundant metabolites relative to
glucose are summarised in Table S1. The quantitative changes
that occurred in individual animals during the course of infection
overlapped with variations in samples collected from different
animals of the same class (control, S. pneumoniae and C. neoformans,
see supporting material, Table S1), precluding the use of
metabolite ratios for diagnosis of streptococcal and cryptococcal
meningitis.
Statistical classification of NMR data
A statistical classification strategy (SCS) [42] (an earlier version
of which was previously used for metabolomic studies in
pathogenic yeasts [16]) was utilised to improve predictability of
class assignment based on NMR spectra, and also to identify
metabolite differences occurring during pathogenesis in the
meningitis models. A genetic-algorithm-based optimal region
selection (GA-ORS) algorithm was used to identify discriminatory
regions in the NMR spectra [34]. The three most discriminatory
spectral regions identified by the GA-ORS for each pair-wise
comparison (S. pneumoniae versus C. neoformans, S. pneumoniae versus
control and C. neoformans versus control) are summarised in Table 1
(B). Metabolites within these spectral regions that were identified
by 2D NMR techniques include the amino acid residues glutamine
(traces of glutamate were found in 10% of the CSF samples
independent of the pathology), valine, leucine, isoleucine; acetate,
lactate, citrate, polyols and carbohydrate residues and a-
hydroxybutyrate. Notably, polyols (mannitol/glycerol) were deter-
mined to contribute to the distinction between C. neoformans and S.
pneumoniae meningitis but not to that between C. neoformans
meningitis and controls, presumably because polyols overlap with
glucose resonances, and glucose levels are higher in normal CSF
than in that from animals with cryptococcal meningitis.
After identification of the most discriminatory regions in the
NMR spectra of CSF, these regions were utilised to distinguish
Table 1. Statistical Classification Strategy using NMR spectra of CSF samples.
(A) SCS analysis with and without blood contaminated CSF samples.
N correct [%] crisp [%]
1. Training set (all incl.)
Control 52 97 73
C.neoformans 25 91 88
S.pneumoniae 24 95 88
1. Validation set (all incl.)
Control 6 50 67
C.neoformans 15 64 93
S.pneumoniae 15 100 87
Final Training set (excl. blood contaminations)
Control 49 96 94
C.neoformans 34 100 94
S.pneumoniae 39 97 92
Final Validation set (excl. blood contaminations)
Control 12 100 92
C.neoformans 6 100 100
S.pneumoniae 61 0 0 8 4
Inclusion of an additional clinical isolate
C.neoformans (WM1128) 5 80 100
S.pneumoniae (99-235-2193) 5 100 80
(B) Spectral regions used for the final SCS-based classifiers and potential metabolites of these regions that were also identified in 2D NMR spectra.
Method Regions [ppm] Potential metabolites
C. neoformans vs. S. pneumoniae Rank-ordered 1
st derivatives 3.91–3.95 polyols (mannitol/glycerol) and carbohydrate residues
2.66–2.70 citrate
2.25–2.27 glutamine
C. neoformans vs. control 1
st derivatives 2.25–2.31 glutamine
1.89–1.92 acetate, glutamine
0.90–0.95 a-hydroxybutyrate, valine, leucine, isoleucine
S. pneumoniae vs. control Rank-ordered 1
st derivatives 1.84–1.92 acetate, glutamine
1.15–1.29 lactate
0.77–0.88 valine, leucine, isoleucine
doi:10.1371/journal.pone.0005328.t001
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classification accuracy was achieved after repeated re-development
and validation of the pair-wise classifiers. The first set of classifiers
were based on all CSF samples (N=101) and was still relatively
inaccurate (Table 1). Although 91–97% of the spectra were
assigned correctly to one of the classes, 12–27% of these
assignments were ‘fuzzy’ (e.g., with low assignment confidence).
These classifiers performed poorly on an independent validation
sample set. It was noted that a high percentage of those spectra
that were fuzzy or incorrect, were visibly contaminated with blood.
Classifier redevelopment following exclusion of samples contam-
inated with blood resulted in final assignments with only 6–8% of
samples classified fuzzy and 4% or less as incorrect (misclassifi-
cation). Testing against a newly acquired, independent validation
set (N=34) from animals that were not part of the data set used for
classifier development, resulted in 8–16% unreliable classification
and 100% correct class assignment (Table 1). Animals were
infected with an additional clinical isolate of C. neoformans
(WM1128, n=5) or S. pneumoniae (99-235-2193, n=5). Both new
isolates were classified mostly correctly (one isolate was misclas-
sified and one was fuzzily assigned).
Repeated CSF collections from the same infected animal
(N=27) were mainly used for classifier validation. The time of
collection of CSF after onset of meningitis did not influence class
assignment. One possible explanation is that quantitative changes
in metabolite composition between day 4 and 11 after infection in
an individual animal were similar to differences in CSF
composition between different animals collected at the same time
point.
Discussion
Micro-NMR spectroscopy of CSF when analysed by a
supervised classification method distinguished rapidly and repro-
ducibly between controls, rats with pneumococcal meningitis and
rats with cryptococcal meningitis. This proof of principle study in
experimental rats indicates that the etiology of meningitis can
potentially be established rapidly without prior culture of the
infection-causing microorganism using a very small amount of
CSF. If able to be translated into clinical practice and extended to
other pathogens, this is potentially a major diagnostic advance that
would assist in the rapid selection of appropriate antimicrobial
therapy and hence improve patient outcomes.
Human CSF is rich in NMR detectable metabolites. More than
hundred have been identified based on NMR spectroscopy in CSF
from patients with various neurological, metabolic and other non-
neurological diseases [29], the most abundant being glucose and
lactate, with lesser amounts of acetate, citrate, formate, 3-
hydroxyl-butyrate, alanine, valine and glutamine [30]. The major
metabolites in CSF samples from humans without infections or
other apparent diseases are similar to those in healthy rats as
observed in the present study (Figure 2). Rat models have
previously proven to be suitable for NMR spectroscopic studies of
staphylococcal and cryptococcal brain abscesses [35,36].
Semi-quantitative analysis revealed that elevation of lactate and
reduction in glucose levels were the dominant CSF metabolite
changes in rats with meningitis. These changes are also
documented in human cases of bacterial and fungal meningitis,
but are not specific [8]. Changes in metabolite concentrations in
CSF samples are due to a combined effect of metabolites from
infecting microorganisms, inflammatory cells and changes due to
the effect of meningitis on brain cell metabolism. For example,
increased lactate levels in CSF may result from anaerobic cerebral
metabolism (glycolysis) which occurs in response to brain cell
ischemia and is a feature of both infectious and non-infectious
neurological disorders [7,37] but it is also a dominant metabolite
of some bacteria under those conditions [38]. Notably, lactate is a
prominent end product of metabolism in S. pneumoniae and levels in
pneumococcal meningitis exceed those produced in individual
human cases of staphylococcal and cryptococcal meningitis [8],
suggesting a contribution from the organisms themselves. Further
evidence of low concentrations of microbial metabolites in the
CSF comes from mannitol identified in 20% of the CSF samples
from animals infected with C. neoformans [39]. Low levels of glucose
in bacterial meningitis might be due to reduced membrane carrier-
facilitated glucose transport, microbial metabolism and increased
cerebral glycolysis secondary to ischemia and cytokine release [7],
but are also seen in subarachnoid hemorrhage [37].
Although some metabolic differences were detected by analys-
ing subjectively chosen spectral regions, discrimination between
the two pathologies and controls would not have been possible if
based solely on these major metabolites. In the present study, the
selection of the most discriminatory regions of the NMR spectra
by GA-ORS suggests that glutamine (2.25–2.27/2.3 ppm) may
have contributed most to the distinction between the three
pathologies (control CSF, cryptococcal and pneumococcal men-
ingitis specimen), which was in principle confirmed by the
comparison of individual integral regions (supporting material,
Table S1). However, other unidentified minor metabolites may
have been more discriminatory, underlining the advantages of
spectral analysis by a statistical classification strategy compared to
assignment of individual, preselected key metabolites. Elevated
glutamine, acetate and the amino acids valine, leucine and/or
isoleucine as well as polyols may have contributed to the
classification between pneumococcal or cryptococcal meningitis
and the respective controls as indicated in the spectral regions of
Table 1. For example, increased glutamine has been observed in
bacterial meningitis [40] and acute subarachnoid haemorrhage
[37] and reflects decreased neuronal activity.
Differences in the relative abundance of recognisable metabo-
lites, exemplified by the integral ratios of lactate, acetate,
glutamine, citrate and polyols relative to glucose in the present
study, were insufficient for classification based on changes in
relative concentrations of those individual compounds. Although
the analysis of NMR spectra by GA-ORS identified most
discriminatory regions that might indicate certain key metabolites,
the complex nature of the spectra with composite resonances
makes it difficult to identify all, even minor contributors to the
successful classification. Such low concentration metabolites are
most likely not recognised by operator-based assignment of the
simultaneously detected resonances. This is particularly true for
the spectral region between 3.5 to 4.0 ppm where many
metabolites resonate, including those of importance for classifica-
tion (for example carbohydrates, polyols like mannitol and all Ha
resonances of amino acid residues). Those metabolites can often
only be identified by time consuming 2D correlation spectra (see
supporting material, Figure S1).
Technical considerations
Accurate classification was achieved in the present study
without any pre-processing of the CSF samples. As also reported
by Maillot [29], contamination of CSF with blood did influence
classification accuracy and resulted in exclusion of 10% of
samples. Blood contamination is a potentially greater problem
with repeated cisternal taps in small animals than it is with a single
spinal fluid collection in humans.
A desirable precondition for the incorporation of NMR
spectroscopy into clinical diagnostics is automation of sample
Classification of Meningitis
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a minimum. Even more important is the utilization of small
volumes for repeated monitoring in animal models. We therefore
chose a 1 mm micro-NMR probe for acquisition of NMR spectra.
Low volumes of CSF samples (5 to 35 ml) were directly collected
into 1 mm micro NMR tubes. Subsequent snap-freezing and later,
automated acquisition of NMR spectra resulted in a satisfactory
signal-to-noise ratio and spectral quality. Comparison between
data acquisition using the 1 mm micro NMR probe with those in
conventional 5 mm tubes confirmed previous findings of dramat-
ically improved signal-to-noise ratios and equal or better spectral
resolution and water suppression by using 1 mm micro tubes [33].
No additional sample preparation was performed apart from
addition of deuterated water (D2O) to some samples (N=30) for
evaluation of spectral quality (resolution) after shimming. No
significant differences were found between these samples and
sample acquisition performed without shimming. Thus the micro-
volume NMR system represents a powerful advance. The stability
of CSF samples at room temperature for some hours makes the
combination of the NMR system with automatic sample changers
feasible, allowing rapid, high-throughput data acquisition and
analysis.
Concluding points
We have demonstrated for C. neoformans and S. pneumoniae
infections that diagnosis of meningitis according to etiology of the
Figure 2.
1H NMR spectra of 100 ml CSF samples from (A) a healthy rat and (B) a human not suffering from meningitis or other
infections. The spectra acquired at 360 MHz using a susceptibility-matched 5 mm NMR tube. Abbreviations refer to
1H NMR signal of the following
metabolites: Ac – acetate, Ala – alanine, b-glc (H-2) – H-2 resonance of b-glucose, Cit – citrate, HDO – remaining, partly deuterated water resonance,
Glc – glucose, Gln – glutamine, Lac – lactate.
doi:10.1371/journal.pone.0005328.g002
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of the microorganism using a metabolomics based approach. The
method can be fully automated and is suitable for incorporation in
clinical diagnosis. This would potentially accelerate and hence
greatly improve turn-around-times compared with current diag-
nostic procedures once it has been extended to other meningitis-
causing pathogens and validated on clinical samples.
Materials and Methods
Ethics statement
Animal experimentation was carried out according to the
Australian National Health and Medical Research Council
Guidelines and with ethical approval from the University of
Sydney Animal Ethics Committee (approval number K14/12-97/
3/2668).
Clinical samples were studied in compliance with ethical
approval granted by the Human Ethics Review Committee of
Sydney Western Area Health Service.
Animal studies
A total number of 175 CSF samples were collected from 76
animals (Fisher 344 rat strain, 150–250 g, Animal Research
Council, Perth, WA, Australia) in this study. Rats were
anaesthetized by inhalation of 2% halothane (May & Baker,
Degenham, UK) in oxygen delivered from a precision out-of-
circuit vaporiser using a tight-fitting facemask. Following induction
of deep anaesthesia, a 25-gauge needle was inserted into the
cisterna magna and 15–35 ml of CSF was removed by suctioning
the hub of the needle using an insulin syringe. These CSF samples
were used as control (sterile) specimens. Meningitis was induced by
the slow injection of 15–35 ml PBS containing 10
4 cfu of clinical
isolates of Cryptococcus neoformans (isolate WM628, 31 rats infected)
or Streptococcus pneumoniae (isolate 99-241-1187, 30 rats infected),
followed by rapid withdraw of the needle. Sham injection was
performed for five animals by injection of sterile PBS. For
validation of the classification five animals per pathogen were
injected using an additional clinical isolates of C. neoformans (isolate
WM1128) and S. pneumoniae (isolate 99-235-2193).
CSF samples (15–35 ml) from infected rats were harvested when
animals first showed signs of meningitis (such as head tilt, seizures,
loss of appetite; typically four to eight days following inoculation)
or after day eight if the animals remained asymptomatic.
Additional collection of CSF was performed three days thereafter
for all animals that had not been euthanized (N=27). CSF was
collected as before from the cisterna magna. Part of the CSF
sample from all animals was used for confirmation of the presence
of microorganisms using standard microbiological tests (10–15 ml
CSF). Only CSF samples from which the respective microorgan-
isms had been cultured were included in the NMR study. The
presence of cryptococcal organisms in CSF was confirmed by thin
smears of CSF (10 ml), which were stained with a rapid
Romanowsky stain (DiffQuik; Lab Aids, Australia). Typically,
large numbers of organisms were evident in stained smears. Plate
counts were performed on CSF samples from thirteen animals (six
C. neoformans and seven S. pneumoniae) by culture of five different
dilutions on horse blood agar plates for 24 hours (S. pneumoniae)
and on Sabouraud dextrose agar plates for 48 hours (C. neoformans)
at 35uC. Three inoculated animals were excluded from the study
due to an absence of microorganisms in CSF samples.
Animals were given free access to food and water ad libitum and
maintained in a 12 hours light/dark cycle at 25uC throughout the
study. Animals were monitored daily for any signs of distress. Rats
were sacrificed after the experiments. Euthanasia was generally
performed with CO2.
Surplus CSF from clinical samples was studied in compliance
with ethical approval granted by the Human Ethics Review
Committee of Sydney Western Area Health Service. CSF from
patients with cryptococcal meningitis were stored at 280uC for up
to three months before NMR analysis. The diagnosis of
cryptococcal meningitis was made independently by attending
clinicians and reviewed by TCS for consistent clinical features.
Leukocyte counts, biochemistry, microbial strains and cultures
were performed for all samples. Cryptococcal meningitis was
defined by a positive India Ink stain and/or CSF cryptococcal
antigen titre .8 and/or culture of C. neoformans from CSF.
NMR studies
Five to fifteen microliters of CSF were directly collected into
micro NMR tubes (1 mm outer diameter, 0.8 mm inner diameter,
Bruker BioSpin AG, Fa ¨llanden, Switzerland). The samples were
transferred within 15 minutes into liquid nitrogen and stored at
270uC for up to 60 days for NMR experiments. Samples were
carefully thawed before NMR experiments and centrifuged for
30 seconds using a manual centrifuge to avoid air bubbles in the
micro tubes. Deuterated water (2–4 ml) was added to 30 samples to
adjust for low filling heights.
NMR experiments were carried out as described [33]. In brief,
1D
1H NMR spectra for SCS analysis were acquired using a
Bruker Biospin Avance 400 spectrometer. Two-dimensional (2D)
correlation NMR spectra for resonance assignment were acquired
using a Bruker Biospin Avance 600 spectrometer. An appropriate
TXI 1 mm MicroProbe with z-gradients was used on either NMR
spectrometer. In addition, NMR spectra were also acquired from
CSF samples collected at the terminal time point (volume 50–
150 ml) using a Bruker Biospin Avance 600 spectrometer equipped
with a 5 mm {
1H,
13C} inverse-detection dual-frequency probe.
All measurements were carried out without spinning at 37uC. 1D
1H NMR spectra were acquired with 16 k data points, a spectral
width of 10 ppm, a repetition time of three seconds and
accumulation of 64 averages. Residual water was suppressed
using an 1D NOESY presaturation sequence with a mixing time of
100 ms [41]. For the suppression of contributions from macro-
molecules and other compounds with short T2 values, the Carr-
Purcell-Meiboom-Gill (CPMG) experiment was performed on a
small set of CSF samples (see supporting material Table S2).
Experimental parameters were: number of repeated cycles 200,
echo time 10 ms.
Resonance assignment. 2D homo- and heteronuclear
correlation spectra were acquired for six to eight CSF samples
per class to assign
1H NMR resonances to respective metabolites





1H} TOCSY experiments were acquired with the
following parameters: spectral width in t2 10 ppm, t2 time domain
2 K, 256 increments of 8 or 16 acquisitions each, relaxation delay
1 s. TOCSY spectra with mixing times of 40 ms were acquired
with 256 increments of 2 K data points and 16 acquisitions.
Standard sensitivity-enhanced gradient inverse-detection HSQC
spectra were acquired with the following parameters: optimisation
for one-bond coupling of 125 and 145 Hz, total of 256 increments
with 32 transients, 4 K complex data points, and
13C decoupling
using GARP-1. HMBC spectra were optimised for one-bond
coupling of 125 Hz and long range coupling constants of 6 Hz.
Relative quantification of metabolites was achieved by integra-
tion of resonances in the chemical shift region between 0.0–
4.0 ppm, following polynomial baseline correction.
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1H NMR spectra of CSF from controls and animals with
confirmed S. pneumoniae and C. neoformans meningitis (obtained
three to eight days after infection) were used to develop three pair-
wise classifiers (for S. pneumoniae versus C. neoformans; C. neoformans
versus control and S. pneumoniae versus control) as described
previously [16,42,43]. In brief: magnitude NMR spectra were
normalized to the total integral between 0.35 to 4.0 ppm, which
contains 1500 data points. Two to three maximally discriminatory
regions of these spectra were identified by a genetic-algorithm-
based Optimal Region Selector (GA-ORS) [34]. These regions are
summarised in Table 1. Using the first derivatives or the rank
ordered first derivatives of the spectral regions, pair-wise Linear
Discriminant Analysis based classifiers were developed. The
robustness of the LDA classifiers was tested using a bootstrap-
based crossvalidation by randomly selecting half of the spectra to
develop the classifiers and the remaining half to validate the
classifiers [44]. This process was repeated 1000 times with random
replacements. The classifiers yielded probabilities of class assign-
ments for the individual spectra. Class assignment was called crisp
if class assignment probabilities were .66%. Software developed
in-house was used for all steps of the statistical classification (IBD,
NRC Canada, Winnipeg) as described before [34,42,43].
Supporting Information
Figure S1
Found at: doi:10.1371/journal.pone.0005328.s001 (0.34 MB
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Found at: doi:10.1371/journal.pone.0005328.s002 (0.03 MB
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